Download presentation
Presentation is loading. Please wait.
1
Precision Genome Engineering in Livestock
Directed Genetic Modification Technologies: An Opportunity for Science-Based Regulatory Reform A Roundtable Workshop January 14, 2015
2
Precision Genetic Editing is a “Game Changer”
High gain, low risk Engineering Genetic Engineering pre-2010 DNA sequences inserted randomly Genome Editing post-2010 Precision DNA changes Rate of HDR <10-7 Rate of HDR 0.4 4x106 X Precision genetics => 1bp change in 3 x 109 bp! Error rates (June 2014) are below minimal detection (10-4)
3
Better Nutrition & Improved Animal Welfare with Changing Environments
Applications of Gene-Edited Animals Global Improved Breeds for local environments Better Nutrition & Improved Animal Welfare with Greater Diversity for Changing Environments Animal Models for Biomedical Testing Patient-Specific Tissues & Cells Personal
4
Livestock Gene Conversion with TALENs
5
TALEN-mediated SNP changes about 10% efficient (pigs)
TALEN-mediated HDR for gene editing 45% efficient, 32% biallelic (pigs) TALEN-mediated SNP changes about 10% efficient (pigs) Cas9/CRISPR-mediated SNP gene-editing average <10% efficient (pigs) Tan et al (2013) PNAS
6
Gene-editing Technology
Relative Risks Nature Biotech. (2013) 31: Gene-editing Technology regulation uncertain Regulated Unregulated Low --- Likelihood of Unintended Change High 6
7
Programmable endonucleases change the paradigm
Used to introduce targeted mutations - Not GE Used to target gene insertion - GE Before regulating targeted mutagenesis consider this: Base pair difference between any two humans ranges from 6 X 106 to 24 X 106 (Jorde et al., (2004). Nature Genetics 36 (11s): S28–33; Tishkoff et al., (2004). Nature Genetics 36 (11s): S21–7) Will not be traceable, i.e. not different from natural mutation From Jim Murray, UC-Davis
8
Transgenic Livestock Development
Lysostaphin, Lysozyme, Lactoferrin Jim Murray & Elizabeth Maga, UC – Davis Jim Murray & Elizabeth Maga, UC-Davis Mark Westhusin & Chuck Long, TAMU Matt Wheeler, Illinois Kevin Wells, University of Missouri Scott Fahrenkrug & Dan Carlson, Recombinetics Chris Rogers, Exemplar Avian Influenza Resistance Helen Sang, Roslin Aquadvantage Salmon, Aquabounty
9
Gene Edited Livestock WT Pitx3 Knockout No Human Stem Cells
RELA African Swine Fever Virus Resistance Warthog to S. scrofus using TALEN in embryos (Roslin Institute & Recombinetics) Recombinetics: PCSK9 Gain-of-Function mutation using transgenic KO LDLR mutation introduced using TALEN in cell cultures Myostatin allele from Belgian Blue to Nelore (B. Taurus to B. Indicus); direct embryo modification using TALEN (TAMU & Recombinetics) Recombinetics WT Pitx3 Knockout No Human Stem Cells + Human Stem Cells
10
FDA Approved Transgenic Livestock
Glofish ® 2003 Atryn® Recombinant Antithrombin, 2009
11
Regulation of GE Animals
United States: Outcome based (in theory); (in truth) process based By FDA as a “New Animal Drug” Guidance-based only, i.e. no statutes Canada: Novel Foods Argentina, Australia, New Zealand: Process-based Europe: fiat Brazil: ???
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.